Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
REDWOOD CITY, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the upcoming TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA on Wednesday, May 29, 2024 at 12:00 p.m. Eastern Daylight Time / 9:00 a.m. Pacific Daylight Time. The presentation will be accessible via Webcast through a link on the Investor Events and Presentations section of the Coherus website: This webcast will be available for replay until June 26, 2024.
加利福尼亞州雷德伍德城，2024年5月23日（GLOBE NEWSWIRE）——Coherus BioSciences, Inc.（Coherus，納斯達克股票代碼：CHRS）今天宣佈，高級管理層將於2024年5月29日星期三美國東部夏令時間中午12點/太平洋夏令時間上午9點出席即將舉行的TD Cowen第五屆年度腫瘤創新虛擬峯會：ASCO和EHA見解。該演示文稿可通過Coherus網站投資者活動和演示部分的鏈接通過網絡直播觀看：該網絡直播將在2024年6月26日之前重播。
Coherus Contact Information:
For Investors:
Jami Taylor
Head of Investor Relations
IR@coherus.com
Coherus 聯繫信息：
對於投資者：
傑米·泰勒
投資者關係主管
IR@coherus.com
譯文內容由第三人軟體翻譯。